17./18. March 2021
Viopas Venture Consulting participates at remote Spark Night event organized by ETH Zürich
Viopas Venture Consulting (VVC) participated as advisor to the Spark Night Pharma and MedTech events organized as remote presentations by the ETH Zürich. Presenting start-up companies in the Pharma/Biotech track were EraCal, InCephalo Therapeutics and Phire Therapeutics and presenting in the MedTech track were aiEndoscopic, Resmonics and Quantactions.
“We are delighted to have participated in the Spark Night event organized by the ETH Zürich and congratulate the start-up companies to their progress,” said Simon Nebel PhD, MBA, Managing Partner at VVC.
3. February 2021
Viopas Venture Consulting participates at Startup Investment Day of ZHAW
Viopas Venture Consulting (VVC) participates as advisor to the Startup Investment Presentations by the Zurich University of Applied Sciences (www.zhaw.ch). Presenting companies were Resmonics.ai, Nala.care and Leitwert.
“We actively seek to engage very early with promising companies in the healthcare sector to scout for attractive investment opportunities for our investor clients and offer our support for young companies in strategic positioning and fund raising,” said Simon Nebel PhD, MBA, Managing Partner at VVC. “We would like to thank the organizers of ZHAW for inviting us to this event ad thank the participating companies for their presentations”
28. January 2021
Viopas Venture Consulting advises Dachverband der Sozialversicherungsträger (Austria)
Viopas Venture Consulting (VVC) advises the Dachverband der Sozialversicherungsträger in Österreich, SV (the Umbrella Organization for Social Services and Health Insurances in Austria) in the evaluation of innovative digital health technologies that might strengthen Austrian public health sector.
“We are pleased having been invited by an expert team of the SV to contribute as external experts in the company pitch day where a series of emerging digital health companies from across Europe presented their technologies and business models,” explained Simon Nebel PhD, MBA, Managing Partner at VVC.
21. December 2020
Viopas Venture Consulting team appointed as Partners of Board Advisors Deutschland AG
Board Advisors Deutschland AG publicly announced the expansion of their advisory services into the Digital Health industry sector and the appointment of Dr. Simon Nebel and Dr. Thomas Meier as Partners.
“We are very pleased that Thomas and Simon will strengthen our team. Relying on their expertise Board Advisors will be able to widen our products and services from the focus area of IT, software, SaaS and IT services into the rapidly growing sector of digital health”, commented Christoph Löslein (Founding Partner at Board Advisors).
“Being part of the Board Advisors team clearly strengthens our reach into the IT world where SaaS business models are well established. The overlap of IT and Digital Health clearly leverages technologies and business concepts, creating attractive investment opportunities”, commented Thomas Meier, PhD, Managing Partner at VVC.
For more information, please see www.boardadvisors.de